• Cardiology prepared for fourth dimension

    Friday March 5th 2021

  • Sarcura and imec to collaborate on high throughput cytometry solution for automated (T-)cell separation

    Thursday February 25th 2021

  • Preventieve speekseltest voor het opsporen van het COVID-19 virus is nu beschikbaar voor bedrijven en organisaties

    Tuesday February 23rd 2021

  • Grapheal raises EUR1.9 million to advance development of embedded biosensing technology and application in digital COVID testing and wound monitoring

    Wednesday February 10th 2021

  • Bone Therapeutics completes recruitment and patient treatment in JTA-004 pivotal Phase III knee osteoarthritis study

    Tuesday December 22nd 2020

  • GSK meets Belgian Universities

    Tuesday October 27th 2020

  • Biocartis announces market release of SeptiCyte® RAPID test on Idylla™

    Tuesday October 6th 2020

  • Jyseleca® (filgotinib) approved by European Commission for rheumatoid arthritis

    Friday September 25th 2020

  • Your news here?

  • Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis

    Friday September 25th 2020

  • Mithra announces commercial launch of Tibelia® in Canada

    Thursday July 30th 2020

  • US multicenter study shows Idylla™ allows rapid and accurate mutation testing results across different laboratory settings

    Friday June 26th 2020

Strategic Partners